Products for Research Use Only
RegisterLogin

PNC-27 (acetate)

CAT: 0804-HY-P3508A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P3508A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PNC-27 acetate, a chimeric p53-penetratin peptide binds to HDM-2 in a p53 peptide-like structure, induces selective membrane-pore formation and leads to cancer cell lysis. PNC-27 acetate is an anticancer peptide. PNC-27 acetate can be used in acute myeloid leukemia research[1][2][3].
UNSPSC
12352209
Target
MDM-2/p53
Type
Peptides
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pnc-27-acetate.html
Purity
99.32
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(N1[C@@H](CCC1)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC3=CNC4=CC=CC=C34)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](CC5=CNC6=CC=CC=C56)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(N)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC7=CC=CC=C7)C(N[C@@H](CC8=CNC9=CC=CC=C89)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H]%10NCCC%10.CC(O)=O.[x]
Molecular Formula
C188H293N53O44S.xC2H2O2
Molecular Weight
4031.73 (free base)
References & Citations
[1]Ehsan Sarafraz-Yazdi, et al. PNC-27, a Chimeric p53-Penetratin Peptide Binds to HDM-2 in a p53 Peptide-like Structure, Induces Selective Membrane-Pore Formation and Leads to Cancer Cell Lysis. Biomedicines. 2022 Apr 20;10 (5) :945. |[2]Sarafraz-Yazdi E, et al. Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes. Proc Natl Acad Sci U S A. 2010 Feb 2;107 (5) :1918-23.|[3]Wang H, et al. Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia. Leukemia. 2020 Jan;34 (1) :75-86.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P3508-01PNC-27
HY-P3509A-01PNC-28 (acetate)
HY-P3509-01PNC-28
HY-P4195A-01[K15, R16, L27]VIP (1-7) /GRF (8-27) (acetate)
HY-166875SApramycin acetate-d7 (acetate)
HY-153702JAK-IN-27
HY-156553BTK-IN-27
HY-178445PI3Kδ-IN-27
HY-175182IDO1-IN-27
HY-173603FAK-IN-27

Alternative Products

CatalogName
MBS5819698PNC-28 acetate
TP1954L-01PHM-27 (human) acetate
FG110171-01GAP 27 acetate salt
T38193L-01β-Endorphin (1-27) (human) acetate
Q-201894-01Triphenylmethane triisocyanate solution, 27% in ethyl acetate
MBS5785341beta-Endorphin (1-27)(Human) acetate
T6956L-01Protirelin Acetate (24305-27-9 free base)
TP1070L-01PACAP (1-27), human, ovine, rat acetate
GTR19150066MART-1 (27-35) (human) acetate salt
MBS5765363Neuropeptide FF acetate (99566-27-5 free base)

Popular Products